Scott Yerby - Si Bone Vice President CTO
| SIBN Stock | USD 14.20 0.41 2.81% |
President
Dr. Scott A. Yerby Ph.D., is Chief Technology Officer of the Company since January 2011. He has served as our Chief Technology Officer since January 2011. Prior to joining us, Dr. Yerby served as Vice President, Research and Development for ProMed, Inc., a medical supply company, from June 2009 to January 2011. From May 2007 to June 2009, Dr. Yerby sat on the board of several nonprofit organizations. From June 2000 to May 2007, Dr. Yerby served as Vice President of Research and Development for St. Francis Medical Technologies, Inc., a spinal manufacturing company, until its acquisition by Kyphon, Inc. From June 1997 to June 2000, Dr. Yerby served as Director of Experimental Biomechanics at the Palo Alto VA Hospital. Early in his career, Dr. Yerby held appointments as Consulting Assistant Professor at Stanford University in the Department of Mechanical Engineering, Division of Biomechanical Engineering, and the Department of Functional Restoration, Division of Orthopedic Surgery since 2011.
| Age | 56 |
| Tenure | 13 years |
| Address | 471 El Camino Real, Santa Clara, CA, United States, 95050 |
| Phone | 408 207 0700 |
| Web | https://si-bone.com |
Si Bone Management Efficiency
The company has return on total asset (ROA) of (0.1512) % which means that it has lost $0.1512 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3238) %, meaning that it created substantial loss on money invested by shareholders. Si Bone's management efficiency ratios could be used to measure how well Si Bone manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of May 2024, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.24. At this time, Si Bone's Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| David Murray | CONMED | 76 | |
| Daniel Jonas | CONMED | 56 | |
| David Bailey | Orthopediatrics Corp | 45 | |
| Stanley Peters | CONMED | 45 | |
| Erick DeVinney | Axogen Inc | 48 | |
| Anthony Borowicz | Integer Holdings Corp | 67 | |
| Carter Houghton | Integer Holdings Corp | 55 | |
| Kimberley Elting | Orthofix Medical | 59 | |
| Joseph Hauser | Orthopediatrics Corp | 41 | |
| Johonna Pelletier | CONMED | 51 | |
| Jon Serbousek | Orthofix Medical | 63 | |
| Tom Thomas | Integer Holdings Corp | 53 | |
| Terence Berge | CONMED | 54 | |
| Tyler Lipschultz | Orthofix Medical | 57 | |
| Jim Stephens | Integer Holdings Corp | 50 | |
| Joel Becker | Integer Holdings Corp | 53 | |
| Stanley III | CONMED | 49 | |
| Kirk Thor | Integer Holdings Corp | 60 | |
| John Kennedy | CONMED | 66 | |
| Joseph Flanagan | Integer Holdings Corp | 61 | |
| Peter Shagory | CONMED | 55 | |
Management Performance
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.15 |
Si Bone Leadership Team
Elected by the shareholders, the Si Bone's board of directors comprises two types of representatives: Si Bone inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SIBN. The board's role is to monitor Si Bone's management team and ensure that shareholders' interests are well served. Si Bone's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Si Bone's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Pisetsky, General Counsel and Chief Compliance Officer | ||
| Laura MBA, CEO Director | ||
| Nikolas Kerr, Strategy Product | ||
| Saqib Iqbal, Director Relations | ||
| Scott Yerby, Vice President CTO | ||
| Anshul Maheshwari, Chief Officer | ||
| Jeff Bertolini, Senior Technology | ||
| Aimee Einstein, Vice Culture | ||
| Joseph Powers, VP Marketing | ||
| Daniel Cher, Senior Affairs | ||
| Anthony Recupero, Chief Commercial Officer | ||
| Carlton Reckling, Chief Medical Officer and Vice President Medical Affairs |
SIBN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Si Bone a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.32) % | ||||
| Current Valuation | 456.09 M | ||||
| Shares Outstanding | 41.2 M | ||||
| Shares Owned By Insiders | 2.37 % | ||||
| Shares Owned By Institutions | 96.58 % | ||||
| Number Of Shares Shorted | 2.59 M | ||||
| Price To Book | 3.63 X |
Currently Active Assets on Macroaxis
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.Note that the Si Bone information on this page should be used as a complementary analysis to other Si Bone's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for SIBN Stock analysis
When running Si Bone's price analysis, check to measure Si Bone's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Si Bone is operating at the current time. Most of Si Bone's value examination focuses on studying past and present price action to predict the probability of Si Bone's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Si Bone's price. Additionally, you may evaluate how the addition of Si Bone to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Si Bone's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 3.614 | Quarterly Revenue Growth 0.216 | Return On Assets (0.15) | Return On Equity (0.32) |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.